Author's reply
2006
Author's Reply on Clinical Trials Registration
publication
Author Information
Author(s): Karmela Krleža-Jerić
Primary Institution: Canadian Institutes of Health Research
Conclusion
Proper registration of clinical trial protocols is essential for transparency and informed decision-making in medicine.
Supporting Evidence
- GSK is committed to registering its trial protocols and results.
- Proper registration will help restore public confidence in the pharmaceutical industry.
- Registration of trial protocols is the first step needed for transparency.
Takeaway
This article talks about how important it is for companies to share information about their medical trials so that doctors and patients can make better choices.
Potential Biases
The author points out that industry registries may not be unbiased.
Limitations
The author acknowledges that not all data for all trials will be registered.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website